2 results
Not approvedWill not start
Primary:To compare the efficacy of abrocitinib 200 mg once daily (QD) versus dupilumab (as per label guidelines) in adult participants on background topical therapy with moderate to severe atopic dermatitis (AD).Key SecondaryTo compare the efficacy…
Approved WMOPending
The primary objective of this proof of concept study is to test the feasibility of sleep deepening using EEG-guided acoustic stimulation as treatment augmentation to a 5-day treatment program for PTSD. In addition, three secondary objectives will be…